Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial

Abstract

In young infants, CIV is associated with earlier and improved attainment of target concentrations compared with IIV. Lower total daily doses are required to achieve target levels with CIV. There is no difference in the rate of drug-related adverse effects.